TNFSF13B and metabolic disease: Several studies have demonstrated that both BAFF and BAFF receptors are expressed in a variety of cell types, including mature adipocytes, playing a role in regulation of energy homeostasis, and proposed that the blockade of BAFF can be considered as a therapeutic approach for the treatment of metabolic diseases [3–5].